Urine Testing Sample Clauses

The Urine Testing clause establishes the requirement for individuals to submit to urine tests, typically to detect the presence of drugs or other prohibited substances. In practice, this clause outlines when and how urine samples must be provided, who may request the testing, and the procedures for handling and analyzing the samples. Its core function is to ensure compliance with substance use policies, promote safety, and provide a clear mechanism for monitoring and enforcing drug-free standards.
Urine Testing. Urine testing will be utilized by the collection official in accordance with the following procedures: 1. The employee to be tested shall: 1. Remove extraneous clothing and personal items (coats, hats, etc); and 2. Remain in full view of the collection official, except when actually providing the sample; 2. If the employee cannot produce a sample, the collection official will allow the employee: 1. To consume up to 40 ounces of water; 2. Up to three hours to provide a suitable specimen. If the employee does not provide a suitable specimen within the three-hour time period, the employee will be considered to have refused the test; 3. Once a suitable urine specimen is obtained, the collection official will: 1. Sign, date, and indicate the time on the Order to Report form; 2. Process the specimen in accordance with accepted laboratory procedures; and 3. Forward the Order to Report form to the appropriate bureau commander;
View SourceView Similar (16)
Urine Testing. Urine testing will be utilized by the collection official in accordance with the following procedures: 1. The employee to be tested shall: 1. Remove extraneous clothing and personal items (coats, hats, etc); and 2. Remain in full view of the collection official, except when actually providing the sample; 2. If the employee cannot produce a sample, the collection official will allow the employee: 1. To consume up to 40 ounces of water; 2. Up to three hours to provide a suitable specimen. If the employee does not provide a suitable specimen within the three-hour time period, the employee will be considered to have refused the test;
View SourceView Similar (3)
Urine Testing. In testing urine samples, the testing laboratory shall test specifically for those drugs and classes of drugs and employing the test methodologies and cutoff levels covered in the DOT Regulations 49 CFR, Part 40.
View SourceView Similar (3)
Urine Testing. The initial testing shall be by immunoassay which meets the requirements of the Food and Drug Administration for commercial distribution. The initial cutoff levels used when screening urine specimens to determine whether they are negative or positive for various classes of drugs shall be those contained in the Scientific and Technical Guidelines for Federal Drug Testing Programs (subject to revision in accordance with subsequent amendments to the HHS Guidelines).
View Source
Urine Testing. In testing urine samples, the testing laboratory shall test specifically for those drugs and classes of drugs listed in Section E.8, employing the test methodologies and cutoff levels specified in Section E.8.
View Source

Related to Urine Testing

  • Random Testing Notwithstanding any provisions of the Collective Agreement or any special agreements appended thereto, section 4.6 of the Canadian Model will not be applied by agreement. If applied to a worker dispatched by the Union, it will be applied or deemed to be applied unilaterally by the Employer. The Union retains the right to grieve the legality of any imposition of random testing in accordance with the Grievance Procedure set out in this Collective Agreement.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act. (B) All classes covered by this Agreement are designated special risk classes for drug testing purposes. Special risk means employees who are required as a condition of employment to be certified under Chapter 633 or Chapter 943, F.S. (C) An employee shall have the right to grieve any disciplinary action taken under section 112.0455, the Drug-Free Workplace Act, subject to the limitations on the grievability of disciplinary actions in Article 10. If an employee is not disciplined but is denied a demotion, reassignment, or promotion as a result of a positive confirmed drug test, the employee shall have the right to grieve such action in accordance with Article 6.

  • ODUF Testing 6.6.1 Upon request from TWTC, AT&T shall send ODUF test files to TWTC. The Parties agree to review and discuss the ODUF file content and/or format. For testing of usage results, AT&T shall request that TWTC set up a production (live) file. The live test may consist of TWTC’s employees making test calls for the types of services TWTC requests on ODUF. These test calls are logged by TWTC, and the logs are provided to AT&T. These logs will be used to verify the files. Testing will be completed within thirty (30) days from the date on which the initial test file was sent.

  • Meter Testing Company shall provide at least twenty-four (24) hours' notice to Seller prior to any test it may perform on the revenue meters or metering equipment. Seller shall have the right to have a representative present during each such test. Seller may request, and Company shall perform, if requested, tests in addition to the every fifth-year test and Seller shall pay the cost of such tests. Company may, in its sole discretion, perform tests in addition to the fifth year test and Company shall pay the cost of such tests. If any of the revenue meters or metering equipment is found to be inaccurate at any time, as determined by testing in accordance with this Section 10.2 (Meter Testing), Company shall promptly cause such equipment to be made accurate, and the period of inaccuracy, as well as an estimate for correct meter readings, shall be determined in accordance with Section 10.3 (Corrections).

  • Stability Testing Patheon will conduct stability testing on the Products in accordance with the protocols set out in the Specifications for the separate fees and during the time periods set out in Schedule C. Patheon will not make any changes to these testing protocols without prior written approval from Client. If a confirmed stability test failure occurs, Patheon will notify Client within [***], after which Patheon and Client will jointly determine the proceedings and methods to be undertaken to investigate the cause of the failure, including which party will bear the cost of the investigation. Patheon will not be liable for these costs unless it has failed to perform the Manufacturing Services in accordance with the Specifications and cGMPs. Patheon will give Client all stability test data and results at Client’s request.